NASH WITH FIBROSIS
Clinical trials for NASH WITH FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new NASH WITH FIBROSIS trials appear
Sign up with your email to follow new studies for NASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for fatty liver: stomach procedure may beat diet alone
Disease control Recruiting nowThis study tests whether a minimally invasive stomach-shrinking procedure (endoscopic sleeve gastroplasty) combined with lifestyle changes is better than lifestyle changes alone for treating a serious liver condition called MASH in people with obesity. The procedure reduces stoma…
Matched conditions: NASH WITH FIBROSIS
Phase: NA • Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New drug aims to reverse liver scarring in NASH/MASH patients
Disease control Recruiting nowThis study tests whether efruxifermin can improve or reverse liver scarring in people with NASH/MASH (a type of fatty liver disease) who have moderate fibrosis but not cirrhosis. About 1650 adults will receive either the drug or a placebo for up to several years. The main goals a…
Matched conditions: NASH WITH FIBROSIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated May 05, 2026 11:54 UTC